Reply to: “DCD consensus and futility in liver transplantation”

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
m-TOR inhibitors: What role in liver transplantation?
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Liver transplantation using Donation after Cardiac Death donors
m-TOR inhibitors: What role in liver transplantation?
Pathological roles of purinergic signaling in the liver
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Volume 42, Issue 4, Pages (April 2005)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Quality measurement and improvement in liver transplantation
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Management of cirrhosis due to chronic hepatitis C
Michael Charlton  Clinical Gastroenterology and Hepatology 
EASL Clinical Practice Guidelines: Wilson’s disease
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Volume 41, Issue 4, Pages (October 2004)
Reply to: “It takes two “eyes” to see in depth”
Hepatology may have problems with putative surrogate outcome measures
Volume 50, Issue 4, Pages (April 2009)
Chetana Lim, Chady Salloum, Daniel Azoulay
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Volume 66, Issue 4, Pages (April 2017)
m-TOR inhibitors: What role in liver transplantation?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
MELD: the holy grail of organ allocation?
Volume 44, Issue 4, Pages (April 2006)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 70, Issue 5, Pages (May 2019)
Presentation transcript:

Reply to: “DCD consensus and futility in liver transplantation” A. Schlegel, M. Kalisvaart, J. Isaac, P. Muiesan  Journal of Hepatology  Volume 69, Issue 1, Pages 257-258 (July 2018) DOI: 10.1016/j.jhep.2018.04.001 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Overview of factors with potential impact on outcomes in DCD liver transplantation. BMI, body mass index; DCD, donation after cardiac death; LT, liver transplantation; NAC, N-acetylcysteine. (This figure appears in colour on the web.) Journal of Hepatology 2018 69, 257-258DOI: (10.1016/j.jhep.2018.04.001) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.